Investor Information - Abzena

Edison Feed

Share Price


Annual Report 2017

Abzena PLC's Annual Report 2017

Business Model – Revenue Generating

Abzena is a revenue generating life sciences group with its headquarters in the UK and two sites in the US. The Group offers a range of complementary services and technologies for the selection, development and manufacture of biopharmaceuticals. These provide two sources of income for the Group:

  • Fee for service income from fixed price and full time equivalent based contracts
  • Technology licence revenues from the development and commercialisation of Abzena inside products – products whose properties have been enhanced with the Group’s proprietary technologies

Read more on Abzena inside

Interim Results 2017

Abzena secures ADC manufacturing services contract

Antibody manufacturing development agreement signed with UCL